Shared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: A randomized control trial
Identificadores
URI: https://hdl.handle.net/10481/111191Metadatos
Mostrar el registro completo del ítemAutor
Granados Santiago, María; Valenza, Marie Carmen; López López, Laura; Prados Román, Esther; Rodríguez Torres, Janet; Cabrera Martos, IreneMateria
Pulmonary disease, chronic obstructive decision making hospital medicine patient participation
Fecha
2020-04-02Referencia bibliográfica
Granados-Santiago M, Valenza MC, Torres-Sánchez I, Cabrera-Martos I, López-Torres I, Moreno-Ramos MJ. Shared decision-making and patient engagement program during acute exacerbation of COPD hospitalization: A randomized control trial. Patient Educ Couns. 2020;103(4):702-708. doi:10.1016/j.pec.2019.12.004
Patrocinador
This research was financed jointly by Fundación Progreso y Salud (FPS), Boehringer Ingelheim España, S.A. (project code: PI-0370-2014), and Oximesa, Praxair. The authors JRT and LPP received financial support through grants for the training of university lecturers (grant numbers FPU: 16/01531 and FPU: 17/00408 respectively) of the Spanish Ministry of Education.Resumen
OBJECTIVE: To evaluate the effectiveness of a shared decision-making and patient engagement (SDM-PE) program concerning in-hospital stay during acute exacerbation of COPD and determine its impact on patients’ perceived health status.
METHODS: Patients were randomly allocated to a control group that received standard treatment or an intervention group that received an individualized SDM-PE program in addition to standard treatment. The SDM-PE program included personalized health care focused on information about the disease, healthcare management, and reinforcement of behaviors regarding nutrition and exercise taking into account patients’ preferences.
RESULTS: A comparative analysis between groups showed a significant improvement in perceived health status at discharge in patients included in the experimental group compared to those in the control group (60.28±21.65 vs. 54.13±22.69, p=0.036). In addition, perceived health status, COPD knowledge, adherence to pharmacological treatment, general functionality, and healthy lifestyle measures were significantly better at 3-month follow-up in the intervention group.
CONCLUSION: An SDM-PE program significantly enhanced all the clinical measures assessed during hospitalization at 3-month follow-up.
PRACTICE IMPLICATIONS: COPD patients and professionals need to work together to select the best care and treatment model for patients, taking into account individual values and preferences.





